Veeral Desai - 07 Jul 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
07 Jul 2022
Transactions value $
-$7,657,704
Form type
4
Date filed
11 Jul 2022, 16:51
Previous filing
28 Jun 2022
Next filing
25 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $319K +319K +114.69% $1.00* 597K 07 Jul 2022 Direct F1
transaction AGL Common Stock Sale -$7.98M -319K -53.42% $25.00 278K 07 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -319K -69.93% $0.00 137K 07 Jul 2022 Common Stock 319K $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 These options were granted on April 27, 2017 and fully vested on April 27, 2021.